Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA3 | P07451 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA6 | P23280 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4442694 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4529231 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4535099 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4533537 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4522933 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4527348 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4529210 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4522093 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4533163 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL4539084 | 1.00 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132441-A1 | METHOD FOR CONCENTRATING PATHOGENS OR NUCLEIC ACID USING ACID ACTIVATED BENTONITE | INDUSTRY ACADEMIC COOPERATION FOUNDATION YONSEI UNIV (KR) | 2026-05-14 | — | — | US | claimed |
| US-12161005-B2 | Light emitting device, method for manufacturing the same, and electronic device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-12-03 | — | — | US | claimed |
| CN-109996875-B | Method for concentrating microorganisms or extracting nucleic acids using DTBP | 注入技术公司 | 2023-11-28 | — | — | CN | claimed |
| US-11753636-B2 | Method for enriching pathogen, using homobifunctional imidoester | INFUSION TECH (KR) | 2023-09-12 | — | — | US | claimed |
| EP-3505628-B1 | METHOD FOR CONCENTRATING MICROORGANISM OR EXTRACTING NUCLEIC ACID USING DTBP | INFUSION TECH (KR) | 2023-05-03 | — | — | EP | claimed |
| US-11603526-B2 | Pathogen lysis and nucleic acid extraction method using zinc oxide nanostar | INFUSION TECH (KR) | 2023-03-14 | — | — | US | claimed |
| US-11584924-B2 | Method for concentrating microorganism or extracting nucleic acid using DTBP | INFUSION TECH (KR) | 2023-02-21 | — | — | US | claimed |
| CN-110191701-B | Composition for enhancing protein strength | 株式会社LG生活健康 | 2023-02-21 | — | — | CN | claimed |
| US-20220149307-A1 | LIGHT EMITTING DEVICE, METHOD FOR MANUFACTURING THE SAME, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-12 | — | — | US | claimed |
| US-20220127494-A1 | METHOD OF COATING A SUBSTRATE, A COATED SUBSTRATE AND RELATED COMPOSITIONS THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-04-28 | — | — | US | claimed |
| US-7790234-B2 | Low dielectric constant materials prepared from soluble fullerene clusters | XYLON LLC | 2010-09-07 | — | — | US | claimed |
| US-20080044642-A1 | Low dielectric constant materials prepared from soluble fullerene clusters | ROSKILDE SEMICONDUCTOR, LLC (US) | 2008-02-21 | — | — | US | claimed |
| US-20080020197-A1 | Porous inorganic solids for use as low dielectric constant materials | ROSKILDE SEMICONDUCTOR LLC (US) | 2008-01-24 | — | — | US | claimed |
| US-20070292700-A1 | Porous materials derived from polymer composites | ROSKILDE SEMICONDUCTOR LLC (US) | 2007-12-20 | — | — | US | claimed |
| WO-2007143029-A1 | POROUS MATERIALS DERIVED FROM POLYMER COMPOSITES | ROSKILDE SEMICONDUCTOR LLC (US) | 2007-12-13 | — | — | WO | claimed |
| WO-2007143025-A2 | POROUS INORGANIC SOLIDS FOR USE AS LOW DIELECTRIC CONSTANT MATERIALS | ROSKILDE SEMICONDUCTOR LLC (US) | 2007-12-13 | — | — | WO | claimed |
| WO-2007143028-A2 | LOW DIELECTRIC CONSTANT MATERIALS PREPARED FROM SOLUBLE FULLERENE CLUSTERS | ROSKILDE SEMICONDUCTOR LLC (US) | 2007-12-13 | — | — | WO | claimed |
| WO-1998024851-A1 | HYBRID INORGANIC-ORGANIC BINDER COMPOSITION AND METHOD OF PREPARING AND USING SAME | FMC CORPORATION (US) | 1998-06-11 | — | — | WO | claimed |
| WO-1998007793-A1 | HYBRID INORGANIC-ORGANIC ENVIRONMENTAL RESISTANT PROTECTIVE COMPOSITIONS | FMC CORPORATION (US) | 1998-02-26 | — | — | WO | claimed |
| US-4002800-A | ADDING AN ORGANOFUNCTIONAL SILANE TO THE ALCOHOLIC OR BENZINE SOLUTION | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1977-01-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132441-A1 | METHOD FOR CONCENTRATING PATHOGENS OR NUCLEIC ACID USING ACID ACTIVATED BENTONITE | ALKBH1, TET2, ALKBH2 | DNM1 3218/4885TSHR 2086/4885MEN1 3452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.